Literature DB >> 26590623

Female genital cosmetic surgery: Investigating the role of the general practitioner.

Tristan Harding, Jenny Hayes, Magdalena Simonis, Meredith Temple-Smith.   

Abstract

BACKGROUND: Labiaplasty, the surgical reduction of the labia minora, has significantly increased in demand in Australia. Although general practice is one gatekeeper for patients requesting labiaplasty, as a referral is necessary to claim Medicare entitlements, there is little information available to assist general practitioners (GPs) in managing these requests for female genital cosmetic surgery.
METHODS: Semi-structured interviews were conducted with health professionals, including GPs, gynaecologists and plastic surgeons. Participants were recruited through the Victorian Primary Care Practice-based Research Network (VicReN), clinical teaching hospitals and snowball sampling. All interviews were digitally recorded, transcribed, and analysed using content and thematic analysis.
RESULTS: Twenty-seven interviews were conducted. All participants were aware of genital labiaplasty; many had patients who were concerned about genital appearance, for which information had often been sought opportunistically. All participants agreed on the need for resources to inform women of normal genital appearance. DISCUSSION: This novel study demonstrates a need for clinical resources for GPs managing requests for genital labiaplasty.

Entities:  

Mesh:

Year:  2015        PMID: 26590623

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  "I Don't See That as a Medical Problem": Clinicians' Attitudes and Responses to Requests for Cosmetic Genital Surgery by Adolescents.

Authors:  Merle Spriggs; Lynn Gillam
Journal:  J Bioeth Inq       Date:  2018-10-19       Impact factor: 1.352

2.  Female genital cosmetic surgery: a cross-sectional survey exploring knowledge, attitude and practice of general practitioners.

Authors:  M Simonis; R Manocha; J J Ong
Journal:  BMJ Open       Date:  2016-09-26       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.